Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MRI correlates of disability in african-americans with multiple sclerosis.
Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis (July/August).
Pitfalls of 3D FLAIR Brain Imaging: A Prospective Comparison with 2D FLAIR.
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Cystoid macular oedema after fingolimod treatment in multiple sclerosis.
Brain Innate Immunity In The Regulation Of Neuroinflammation: Therapeutic Strategies By Modulating Cd200-Cd200r Interaction Involve The Cannabinoid System.
The Contributions of Solar Ultraviolet Radiation Exposure and Other Determinants to Serum 25-Hydroxyvitamin D Concentrations in Australian Adults: The AusD Study.
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Acquired channelopathies as contributors to development and progression of multiple sclerosis.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Expanding the Clinical Indications for Alpha-1-Antitrypsin Therapy.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Myeloid microvesicles are a marker and therapeutic target for neuroinflammation.
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
The role of mast cells in neuroinflammation.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Small molecule glutaminase inhibitors block glutamate release from stimulated microglia.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Resilience and vulnerability in individuals with chronic pain and physical disability.
Multiple sclerosis: managing a complex neurological disease.
Pages
« first
‹ previous
…
262
263
264
265
266
267
268
269
270
…
next ›
last »